VIM
CRL icon

Vinva Investment Management’s Charles River Laboratories CRL Stock Holding History

Vinva Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Buy
+910
New +$162K ﹤0.01% 449
2026
Q1 		– Sell
-1,132
Closed -$341K – 455
2025
Q4 		$341K Sell
1,132
-2,592
-70% -$470K ﹤0.01% 363
2025
Q3 		$832K Buy
+3,724
New +$591K 0.02% 338

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vinva Investment Management's CRL Position: Q2 2026 in Review

Vinva Investment Management opened a new position in Charles River Laboratories (CRL) in Q2 2026: 910 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #449 among its holdings. This is a return to the name: Vinva Investment Management previously reported a position in CRL as recently as Q4 2025.

Vinva Investment Management first reported a position in CRL in Q3 2025 and has held it in 3 quarters since. The position peaked at $832K in Q3 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Vinva Investment Management held 910 shares of Charles River Laboratories worth $298K as of Q2 2026.
  • Charles River Laboratories was a new Vinva Investment Management position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Vinva Investment Management's portfolio in Q2 2026, its #449 holding.
  • Vinva Investment Management first reported a position in Charles River Laboratories in Q3 2025 and has held it in 3 quarters since.
  • Vinva Investment Management's Charles River Laboratories position peaked at $832K in Q3 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.